Q2 2024 saw record net sales and improved margins for Redsense Medical, driven by US home hemodialysis growth and major investment from ShapeQ. The company is preparing to launch the Redsense Clamp and expand internationally.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.